Last update 01 Nov 2024

Adrixetinib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mechanism
AXL inhibitors(AXL receptor tyrosine kinase inhibitors), CSF-1R antagonists(Colony stimulating factor 1 receptor antagonists), MerTK inhibitors(Tyrosine-protein kinase Mer inhibitors)
Inactive Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC25H24F3N5O5
InChIKeyBWUUJXXFCSYLFW-UHFFFAOYSA-N
CAS Registry2394874-66-7

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
US
12 Jan 2023
Advanced Malignant Solid NeoplasmPhase 2
KR
12 Jan 2023
Esophageal CarcinomaPhase 2
KR
12 Jan 2023
Esophageal CarcinomaPhase 2
US
12 Jan 2023
Hepatocellular CarcinomaPhase 2
KR
12 Jan 2023
Hepatocellular CarcinomaPhase 2
US
12 Jan 2023
Stomach CancerPhase 2
KR
12 Jan 2023
Stomach CancerPhase 2
US
12 Jan 2023
Uterine Cervical CancerPhase 2
US
12 Jan 2023
Uterine Cervical CancerPhase 2
KR
12 Jan 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
30
ruowoafocd(bpcqblqzdz) = kvwswrqcqk moskirexuo (qukccsipfc )
Positive
02 Nov 2023
ruowoafocd(bpcqblqzdz) = yfjznscydd moskirexuo (qukccsipfc )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free